Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, AIM Vaccine Co's Enterprise Value is HK$10,160 Mil.
AIM Vaccine Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-2,436 Mil. Therefore, AIM Vaccine Co's EV-to-EBIT ratio for today is -4.17.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, AIM Vaccine Co's Enterprise Value is HK$10,160 Mil.
AIM Vaccine Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-2,245 Mil. Therefore, AIM Vaccine Co's EV-to-EBITDA ratio for today is -4.53.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, AIM Vaccine Co's Enterprise Value is HK$10,160 Mil.
AIM Vaccine Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,299 Mil. Therefore, AIM Vaccine Co's EV-to-Revenue ratio for today is 7.82.
AIM Vaccine Co Enterprise Value Historical Data
The historical data trend for AIM Vaccine Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of AIM Vaccine Co's Enterprise Value
For the Biotechnology subindustry, AIM Vaccine Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AIM Vaccine Co's Enterprise Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, AIM Vaccine Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where AIM Vaccine Co's Enterprise Value falls into.
AIM Vaccine Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
AIM Vaccine Co's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AIM Vaccine Co (HKSE:06660) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
AIM Vaccine Co's current Enterprise Value is HK$10,160 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. AIM Vaccine Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-2,436 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
AIM Vaccine Co's current Enterprise Value is HK$10,160 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. AIM Vaccine Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-2,245 Mil.
AIM Vaccine Co's current Enterprise Value is HK$10,160 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. AIM Vaccine Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,299 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AIM Vaccine Co Enterprise Value Related Terms
Thank you for viewing the detailed overview of AIM Vaccine Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
AIM Vaccine Co Ltd is a top full-chain vaccine corporation in China with businesses covering the whole industrial chain ranging from research and development, manufacturing and commercialization. The products available for sale mainly include Recombinant HBV vaccine, Human rabies vaccine, HFRS Vaccine, hepatitis A vaccine (human diploid cell), Group A, C, Y and W135 MPSV, mumps vaccine, freeze-dried human rabies vaccine (Vero cell) and ACYW135 meningococcal polysaccharide vaccine. Geographically, the company generates all of its revenues in the PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06660 has been successfully added to your